Edith M. Lord

7.3k citations

139 papers · 6.1k indexed · 1 hit paper · h-index 41

Impact in

Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 73
- Immunotherapy and Immune Responses 49
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 18
Cancer Research 30
- Cancer, Hypoxia, and Metabolism 24

Co-authors: John G. Frelinger Scott A. Gerber Amit A. Lugade C. J. Koch Robert C. Rose Sydney M. Evans Elizabeth W. Sorensen Daniel P. Stites
Journals: The Journal of Immunology (22 papers)International Journal of Cancer (7 papers)Radiation Research (6 papers)Cellular Immunology (6 papers)Journal of Immunological Methods (5 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Edith M. Lord

137 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor 2005 · 775 citations

Peers

Countries citing papers authored by Edith M. Lord

Since Specialization

Citations

This map shows the geographic impact of Edith M. Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith M. Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith M. Lord more than expected).

Fields of papers citing papers by Edith M. Lord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith M. Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith M. Lord. The network helps show where Edith M. Lord may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Edith M. Lord, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edith M. Lord Line = papers co-authored together Edith M. Lord links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combination of NKG2A and PD-1 Blockade Improves Radiotherapy Response in Radioresistant Tumors The Journal of Immunology ·Ed Herrera, 佑子南, 頼子上月, Angela Hughson, F. Jáchym, D. Liu, Scott A. Gerber, Edith M. Lord	2022	15
2	Coadministration of a Clinically Relevant Dexamethasone Dosage With Ablative Radiation Therapy Reduces Peripheral Lymphocytes But Does Not Alter In Vivo Intratumoral Lymphocyte Phenotype or Inhibit Efficacy of Radiation Therapy in a Murine Colorectal Tumor Model International Journal of Radiation OncologyBiologyPhysics ·Ed Herrera, 頼子上月, V.H. Hight, Ishiwata Takashi, D. Liu, Haoming Qiu, Scott A. Gerber, Edith M. Lord	2021	1
3	Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer Cancer Immunology Research ·Jian Ye, Bradley N. Mills, B.M. Haines, Booyeon J. Han, 佑子南, 青森県今別町立今別中学校, Carl J. Johnston, Edith M. Lord, Brian A. Belt, David C. Linehan, Scott A. Gerber	2019	29
4	IFN-γ Mediates the Antitumor Effects of Radiation Therapy in a Murine Colon Tumor American Journal Of Pathology ·Scott A. Gerber, Abigail L. Sedlacek, Kyle R. Cron, Shawn P. Murphy, John G. Frelinger, Edith M. Lord	2013	101
5	The importance of type I interferons in radiation-mediated antitumor responses (162.33) The Journal of Immunology ·Joanne Y. H. Lim, Scott A. Gerber, Edith M. Lord	2012	1
6	Development of an attenuated interleukin-2 cytokine fusion protein that can be activated by tumor expressed matrix metalloproteinases (165.19) The Journal of Immunology ·Yusi Liao, John Puskas, Abigail L. Sedlacek, Edith M. Lord, Ranjana Sheel	2011	2
7	Radiation-Induced IFN-γ Production within the Tumor Microenvironment Influences Antitumor Immunity The Journal of Immunology ·Amit A. Lugade, Elizabeth W. Sorensen, Scott A. Gerber, M.R. Mamat, John G. Frelinger, Edith M. Lord	2008	392
8	Preferential Attachment of Peritoneal Tumor Metastases to Omental Immune Aggregates and Possible Role of a Unique Vascular Microenvironment in Metastatic Survival and Growth American Journal Of Pathology ·Scott A. Gerber, Viktoriya Rybalko, Chad E. Bigelow, Amit A. Lugade, Thomas H. Foster, John G. Frelinger, Edith M. Lord	2006	146
9	Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor The Journal of Immunology ·Amit A. Lugade, M.R. Mamat, Scott A. Gerber, Robert C. Rose, John G. Frelinger, Edith M. Lord Hit paper breakdown →	2005	775
10	Detection of hypoxia in human squamous cell carcinoma by EF5 binding. PubMed ·Sydney M. Evans, Stephen M. Hahn, Pierre Delion, W. Timothy Jenkins, Ara A. Chalian, Paul J. Zhang, Craig W. Stevens, Randall S. Weber, Gregory S. Weinstein, Ivor Benjamin, Natasha Mirza, Mark R. Morgan, Qingxiu Ye, W. Gillies McKenna, Edith M. Lord, Cameron J. Koch	2000	161
11	In Vivo Behavior of Peptide-Specific T Cells During Mucosal Tolerance Induction: Antigen Introduced Through the Mucosa of the Conjunctiva Elicits Prolonged Antigen-Specific T Cell Priming Followed by Anergy The Journal of Immunology ·Rita M. Egan, Chris Yorkey, R.A. Black, Geri Sorrentino, Julia L. Stevens, Eugene Storozynsky, Edith M. Lord, John G. Frelinger, Jerold G. Woodward	2000	61
12	Imaging Hypoxia in Diseased Tissues Advances in experimental medicine and biology ·Sydney M. Evans, M. Bergeron, Donna M. Ferriero, Frank R. Sharp, Heiko Hermeking, Richard N. Kitsis, David L. Geenen, Shani Bialik, Edith M. Lord, C. J. Koch	1997	12
13	2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. PubMed ·Sydney M. Evans, W. Timothy Jenkins, Barbara Joiner, Edith M. Lord, C. J. Koch	1996	91
14	Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker. PubMed ·Nahid Waleh, Isahg Adam, Merrill Knapp, Holly L. Mendonca, Edith M. Lord, C. J. Koch, Keith R. Laderoute, R. M. Sutherland	1995	68
15	B7-1 Enhances Natural Killer Cell-Mediated Cytotoxicity and Inhibits Tumor Growth of a Poorly Immunogenic Murine Carcinoma Cellular Immunology ·Jing Xing Fan, Beth A. Pulaski, Melody L. Woods, Alexander J. McAdam, Anthony A. Gaspari, John G. Frelinger, Edith M. Lord	1995	43
16	Synergistic effects of co‐expression of the Th1 cytokines il‐2 and IFNγ on generation of murine tumor‐reactive cytotoxic cells International Journal of Cancer ·Alexander J. McAdam, Beth A. Pulaski, Stephanie Harkins, Ajmir Bin, Edith M. Lord, John G. Frelinger	1995	24
17	Tumor necrosis factor-mediated cytotoxicity by tumor-associated macrophages Cellular Immunology ·Kim Wilson, Gregg Siegal, Edith M. Lord	1989	10
18	Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle Biochemistry ·Rase Horn H, Robert L. Marraccino, Peter C. Keng, Robert A. Bambara, Edith M. Lord, Jong-Hyok Ri, Sayeeda B. Zain	1989	128
19	Molecular analysis of deficient class I H-2 antigen expression by mouse lung carcinoma cells. The Journal of Immunology ·David W. Bahler, Karen Cerosaletti, Edith M. Lord, John G. Frelinger	1988	14
20	Cell cycle dependent activities of DNA polymerases .alpha. and .delta. in Chinese hamster ovary cells Biochemistry ·Robert L. Marraccino, Alan F. Wahl, Peter C. Keng, Edith M. Lord, Robert A. Bambara	1987	22

About Edith M. Lord

Edith M. Lord is a scholar working on Immunology, Cancer Research, Oncology, Biotechnology and Immunology and Allergy, having authored 139 papers that have together received 6.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (49 papers), Immune Cell Function and Interaction (26 papers), Cancer, Hypoxia, and Metabolism (24 papers), Cancer Immunotherapy and Biomarkers (21 papers), T-cell and B-cell Immunology (18 papers), Cancer Cells and Metastasis (16 papers), CAR-T cell therapy research (14 papers) and Angiogenesis and VEGF in Cancer (10 papers). The work is most often cited by research in Immunology (2.5k citations), Oncology (2.2k citations), Cancer Research (1.1k citations), Radiology, Nuclear Medicine and Imaging (990 citations) and Biotechnology (293 citations). Edith M. Lord has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include John G. Frelinger, Scott A. Gerber, Amit A. Lugade, C. J. Koch, Robert C. Rose, Scott A. Gerber, Sydney M. Evans, Elizabeth W. Sorensen, Daniel P. Stites and George F. Sensabaugh. Their work appears in journals such as The Journal of Immunology, International Journal of Cancer, Radiation Research, Cellular Immunology and Journal of Immunological Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact